million beef cattle are at risk of bovine respiratory diseases in the United States contracting lung infections annually leading to $1 billion in losses due to mortality and morbidity. Isomark’s non-invasive technology also can provide real-time results at the Chute site, in contrast to current diagnostic tests which require hours or days for laboratory analysis. Isomark's technology saves significant costs due to care and drugs specifically help reduce the use of antibiotics thus improving meat quality for consumers.